It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Medical Information Request
Medical Information Request

Latest Updates:  February 2024

Data were updated in the following topics


As of 25-Sep-2023, a total of approximately 3,294 patients with relapsing multiple sclerosis (RMS) received ofatumumab in clinical trials including the ongoing open-label extension and there was approximately 112,482 patient-years post marketing experience1

01_Complate and ongoing clinical tarils_post marketing_v2.jpg
Hone_Image_Button

Report an adverse event

References
1. Data on File. Periodic Safety Update Report (Cut-off date: 25 March 2023); Novartis Pharma AG.

**Last update included exposure, Ig levels, PML, malignancies, fatalities, COVID-19, pregnancy, pivotal trial, references and FAQ sections